NSETrading Window2h ago · 25 Sept 2026, 03:44 pm

Trading Window

Windlas Biotech Limited · WINDLAS

✦ AI Summary

Windlas Biotech Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, from October 1, 2026, till the expiry of 48 hours after the unaudited financial results of the Company for the quarter and half year ended September 30, 2026, becomes generally available information.

Analysis Scores

Earnings Impact5/10
Growth Catalyst5/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Windlas Biotech Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Attachments (1)

📄

WINDLAS_25092026154424_TWCP_Intimation_250926.pdf

pdf

Download →
View document text
Windlas Biotech Limited Reg. Off.: 40/1, Mohabewala Industrial Area Dehradun, Uttarakhand 248 110, India Tel.:+91-135-6608000-30, Fax:+91-135-6608199 Corp. Off.: 705-706, Vatika Professional Point, Sector-66, Golf Course Ext. Road, Gurgaon, Haryana 122 001, India Tel.:+91-124-2821030 CIN-L74899UR2001PLC033407 September 25, 2026 To Listing / Compliance Department Listing / Compliance Department National Stock Exchange of India Limited BSE Limited Exchange Plaza, C-1, Block G Phiroze Jeejeebhoy Towers Bandra Kurla Complex Dalal Street, Mumbai – 400 001 Bandra (E), Mumbai – 400 051 BSE CODE: 543329 NSE SYMBOL: WINDL0AS Dear Sir/ Madam, Sub: Intimation of Closure of Trading Window This is to inform you that as per the Company’s Code of Conduct for Regulating, Monitoring & Reporting of Trading, the Trading Window will be closed for trading in the Company’s securities from October 1, 2026, till the expiry of 48 hours after the unaudited financial results of the Company for the quarter and half year ended September 30, 2026, becomes generally available information. This is for your information and record. Thanking you, Yours faithfully, For Windlas Biotech Limited Ananta Narayan Panda Company Secretary & Compliance Officer www.windlas.com